Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

New Debt Facility

4 Dec 2009 07:00

RNS Number : 5790D
Ferrexpo PLC
04 December 2009
 



4 December 2009

Ferrexpo plc

("Ferrexpo" or "the Company")

 

New Debt Facility

Ferrexpo is pleased to announce that it has secured a new Pre-Export Financing ("PXF") facility in an amount of US$230 million (the "Loan"). 

This transaction is the first successful financing to be concluded by a metals and mining company with assets located in the CIS since the global financial crisis began in September 2008. 

Deutsche Bank AG acted as Coordinator, Mandated Lead Arranger and Bookrunner for the Loan and provided funding, together with 10 other prominent financial institutions, including:

WestLB AG, London Branch

J.P. Morgan plc

BNP Paribas (Suisse) SA

UBS Investment Bank

Fortis Bank (Nederland) N.V.

Stichting Pensioenfonds Zorg en Welzijn

Natixis

CALYON

Raiffeisen Zentralbank Österreich AG

VTB Bank (France) SA

The Loan will be available for drawdown from 1 January 2010, and will be used for financing and general corporate purposes. The Loan matures 36 months from 1 January 2010 and is to be repaid in 24 equal monthly instalments with the first instalment falling due in January 2011. The margin of the Loan is 7.00% above US dollar LIBOR.

Kris Van BroekhovenDeutsche Bank's Head of Structured Commodity and Trade Finance for EMEA, said:

"Deutsche Bank is pleased to have been able to assist Ferrexpo in this debt financing. Ferrexpo's strong performance in the downturn, its business record and commitment to best practice make it an attractive customer to international financial institutions."

Chris MaweChief Financial Officer of Ferrexpo, said:

"Ferrexpo is pleased to have successfully renewed its debt facilities despite extremely challenging debt market conditions. The Company's ability to attract financing from both existing and new lenders is testament to the strength of its relationships with many of the world's leading banks. This is as a result of its commitment to transparency and best practice corporate governance, the Company's strong fundamentals, its financial performance over the past twelve months and the ongoing resilience of its business model. The new PXF will provide Ferrexpo with the necessary financial flexibility to invest the cash flow generated by its existing business in the development of its world class iron ore resources."

For further information, please contact:

Ferrexpo: +44 20 7389 8304

Gavin Mackay

Pelham: +44 20 7337 1500

Charles Vivian

Evgeniy Chuikov

Notes to Editors:

Ferrexpo is a Swiss headquartered resources company with assets in Ukraine, principally involved in the production and export of iron ore pellets, used in producing steel. Current output is over 9 million tonnes, most of which is exported to steelmakers around the world. The Group is listed on the main market of the London Stock Exchange under the ticker FXPO. For further information please visit www.ferrexpo.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPADEFKNFFE
Date   Source Headline
11th Sep 20207:00 amRNSFerrexpo 2020 Special Interim Dividend Declaration
10th Sep 20208:09 amRNSInvestor Presentation
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSLucio Genovese appointed Chairman of Ferrexpo
14th Aug 20204:13 pmRNSNotice of General Meeting
5th Aug 20207:05 amRNSHalf-year Report
8th Jul 20205:15 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSProduction report for 2Q 2020
6th Jul 20207:00 amRNSManagement Changes
3rd Jul 20201:46 pmRNSDirector/PDMR Shareholding
29th Jun 20207:00 amRNSReport on Payments to Governments
19th Jun 20207:00 amRNSCourt Appeal
15th Jun 20207:00 amRNS2020 Interim Dividend Declaration
4th Jun 20209:25 amRNSDirector Declaration
3rd Jun 20207:11 amRNSCourt of Appeal Ruling
28th May 20202:40 pmRNSAGM Statement
18th May 202011:53 amRNSDirector/PDMR Shareholding
18th May 20207:00 amRNSManagement Changes
28th Apr 202011:31 amRNSNotice of AGM
27th Apr 20203:23 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 202011:50 amRNSFerrexpo 2019 Final Dividend
21st Apr 202011:49 amRNS2019 Annual Report and Accounts
9th Apr 202011:44 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSProduction for 1Q 2020
6th Apr 20203:40 pmRNSDirector/PDMR Shareholding
20th Mar 20204:48 pmRNSSecond Price Monitoring Extn
20th Mar 20204:41 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNS2019 Full Year Results
31st Jan 20207:00 amRNSCourt Appeal
20th Jan 20202:20 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
2nd Jan 20207:00 amRNSFerrexpo Special Interim Dividend
14th Nov 20198:50 amRNSAppointment of Acting Chief Financial Officer
12th Nov 20191:51 pmRNSUpdate statement on AGM voting results
6th Nov 20191:21 pmRNSHolding(s) in Company
1st Nov 201910:11 amRNSDirector Declaration
28th Oct 20197:00 amRNSAppointment of Acting Chief Executive Officer
22nd Oct 20195:13 pmRNSDirector Declaration
14th Oct 20197:00 amRNSBoard Statement
8th Oct 20197:00 amRNS3Q 2019 Production Report
30th Sep 20197:00 amRNSResponse to allegations made on social media
4th Sep 20194:17 pmRNSDirector/PDMR Shareholding
30th Aug 20197:00 amRNSConclusions of the Independent Review Committee
19th Aug 20197:00 amRNSAppointment of Senior Independent Director
12th Aug 20197:00 amRNSBoard Appointment
2nd Aug 20197:00 amRNS2019 Half Year Results
5th Jul 20197:00 amRNSProduction for 2Q 2019 and Trading Update
3rd Jul 201911:53 amRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAppointment of Auditor
27th Jun 20195:13 pmRNSReport on Payments to Govts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.